相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial
Susumu Sakamoto et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Systematic Review and Meta-analysis of Pirfenidone, Nintedanib, and Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
Enrica Di Martino et al.
ANNALS OF PHARMACOTHERAPY (2021)
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial
Juergen Behr et al.
LANCET RESPIRATORY MEDICINE (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings
Linan Zeng et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
Steven D. Nathan et al.
LANCET RESPIRATORY MEDICINE (2021)
GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
Nancy Santesso et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed A. C. Siemieniuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework
Romina Brignardello-Petersen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
Ganesh Raghu et al.
LANCET RESPIRATORY MEDICINE (2019)
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
Toby M. Maher et al.
LANCET RESPIRATORY MEDICINE (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
Nasreen Khalil et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis
Aristeidis Skandamis et al.
JOURNAL OF DRUG ASSESSMENT (2019)
Commentary: Statistical significance and clinical significance - A call to consider patient reported outcome measures, effect size, confidence interval and minimal clinically important difference (MCID)
Michael Fleischmann et al.
JOURNAL OF BODYWORK AND MOVEMENT THERAPIES (2019)
Impact of Lung Function Decline on Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis (IPF)
M. Kreuter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis A Randomized Clinical Trial
Ganesh Raghu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
Romina Brignardello-Petersen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
Martin Kolb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis Results of the INJOURNEY Trial
Carlo Vancheri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial
Ganesh Raghu et al.
LANCET RESPIRATORY MEDICINE (2017)
Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis
Gert van Valkenhoef et al.
RESEARCH SYNTHESIS METHODS (2016)
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
Bram Rochwerg et al.
BMC MEDICINE (2016)
Drug Treatment of Idiopathic Pulmonary Fibrosis Systematic Review and Network Meta-Analysis
William J. Canestaro et al.
CHEST (2016)
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
Bernt van den Blink et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Understanding the effect size and its measures
Cristiano Ialongo
BIOCHEMIA MEDICA (2016)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
Hui Huang et al.
MEDICINE (2015)
Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis
Yasunari Miyazaki et al.
RESPIRATORY INVESTIGATION (2015)
Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
Tamera J. Corte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan A Parallel, Randomized Trial
Ganesh Raghu et al.
ANNALS OF INTERNAL MEDICINE (2013)
Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction
MeiLan K. Han et al.
CHEST (2013)
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Graphical Tools for Network Meta-Analysis in STATA
Anna Chaimani et al.
PLOS ONE (2013)
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis
Sakae Homma et al.
RESPIROLOGY (2012)
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Kenneth E. Lipson et al.
FIBROGENESIS & TISSUE REPAIR (2012)
A Small Change in FVC But a Big Change for IPF Defining the Minimal Clinically Important Difference
Juergen Behr
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
GRADE guidelines: 7. Rating the quality of evidence-inconsistency
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 8. Rating the quality of evidence-indirectness
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 5. Rating the quality of evidence-publication bias
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias)
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
David A. Zisman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Serum Amyloid P Inhibits Fibrosis Through FcγR-Dependent Monocyte-Macrophage Regulation in Vivo
Ana P. Castano et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
GRADE:: what is quality of evidence and why is it important to clinicians?
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Effect size, confidence interval and statistical significance: a practical guide for biologists
Shinichi Nakagawa et al.
BIOLOGICAL REVIEWS (2007)
Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P
Darrell Pilling et al.
JOURNAL OF IMMUNOLOGY (2007)
Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis
Eleni G. Tzortzaki et al.
RESPIRATORY MEDICINE (2007)
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
K. M. Antoniou et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
High-dose acetylcysteine in idiopathic pulmonary fibrosis
M Demedts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Anticoagulant therapy for idiopathic pulmonary fibrosis
H Kubo et al.
CHEST (2005)
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
A Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis
H Tomioka et al.
RESPIROLOGY (2005)
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales
DE Warn et al.
STATISTICS IN MEDICINE (2002)
分享论文
